Advertisement Alpha Innotech Posts $3.6 Million Revenues In Q1 2009 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Alpha Innotech Posts $3.6 Million Revenues In Q1 2009

Alpha Innotech Corp. (Alpha Innotech) has reported revenues of $3.69 million for the first quarter of 2009, up 1%, compared with the revenues of $3.67 million in the year-ago quarter. It has reported net income applicable to common stockholders of $0.21 million, or $0.02 per share, for the first quarter of 2009, compared with the net loss applicable to common stockholders of $2,057 or $0.00 per share, in the year-ago quarter.

Excluding interest, depreciation and stock-based compensation on a non-GAAP basis, the Company had net income of $203,698 for the first quarter of 2009 compared to $338,310 for the first quarter of 2008. The non-GAAP net income (loss) is reconciled to comparable GAAP net income (loss) in the table entitled “Non-GAAP Calculation of Net Income.”

“Our 1% revenue increase does not reflect the fact that our new orders increased 17% in the first quarter of 2009 compared to the first quarter of 2008. By comparison, our first quarter of 2008 benefitted from a significantly larger beginning backlog as well as a one-time gain from a patent sale,” said Ron Bissinger, chief executive officer of Alpha Innotech.

Recent Highlights

Launched SpectraPlex, a multicolor fluorescent Western blotting kit optimized for use on the company’s FluorChem Q imager

Added sales personnel in China and India to continue building revenue-generating capabilities in the rapidly growing Asia region

Launched a portfolio of new service products allowing customers to choose from a variety of service and support options.

Alpha Innotech manufactures and sells analytical laboratory instruments, software and consumables used in life science research laboratories for the study of nucleic acids, proteins and cells.